FDA 483 - Hawaii Pharm LLC - November 07, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Hawaii Pharm LLC in Honolulu, HI, a dietary supplement manufacturer, revealed significant deficiencies in their manufacturing processes. The firm failed to establish identity and product specifications, prepare master manufacturing and batch production records, and maintain proper complaint handling procedures. Additionally, issues were noted with reserve sample collection and supplier qualification documentation, indicating a broad lack of adherence to good manufacturing practices.
ID · 5580d04e-f9a0-4a6f-bd1f-71cce92b8436